文献速递内脏/肾动脉与血管畸形

内脏动脉瘤管理的系统综述与Meta分析

A systematic review and meta-analysis of the management of visceral artery aneurysms.
PubMed 文献 · J Vasc Surg · 2020-01-01

该系统综述纳入80项观察性研究、2845个内脏动脉瘤,比较开放手术与腔内治疗。两组死亡率无统计学差异;腔内治疗住院更短、心血管并发症更少但再干预率更高。假性动脉瘤死亡与再干预率倾向更高。

要点

  • 开放与腔内治疗死亡率无统计学差异。
  • 腔内治疗住院更短、心血管并发症更少,但再干预率更高。
  • 假性动脉瘤死亡率和再干预率倾向更高。

核心结论

  • 开放手术与腔内治疗的内脏动脉瘤患者死亡率差异无统计学意义。
  • 腔内治疗与更短住院时间和更低心血管并发症率相关,但与更高再干预率相关。
  • 假性动脉瘤的死亡率和再干预率倾向更高。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、EMBASE、Cochrane和Scopus数据库。
  • 纳入80项观察性研究,多为非比较性研究。
  • 共2845个动脉瘤,包括肾动脉1279个、脾动脉775个、肝动脉359个等。

主要发现

  • 开放与腔内治疗死亡率差异无统计学意义。
  • 腔内治疗使用更频繁,住院更短、心血管并发症更低,但再干预率更高。
  • 栓塞后综合征率从9%(肾动脉)到38%(脾动脉)。
  • 弹簧圈迁移率从8%(脾动脉)到29%(肾动脉)。
  • 假性动脉瘤死亡率和再干预率倾向更高。

关键数值与推荐

  • 栓塞后综合征率:肾动脉9%,脾动脉38%。
  • 弹簧圈迁移率:脾动脉8%,肾动脉29%。
  • 其他入路部位并发症率低于5%。

临床怎么用

  • event rates有助于医患共享决策,需结合外科专长和解剖可行性。
  • 腔内治疗可缩短住院并减少心血管并发症,但需权衡再干预风险。
  • 假性动脉瘤患者可能需更积极监测再干预。

局限性

  • 证据确定性低,主要基于观察性研究。
  • 多数研究为非比较性设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The evidence supporting management decisions of visceral artery aneurysms (VAAs) is sparse. Practice guidelines are needed to help patients and surgeons choose between endovascular and open surgery approaches. METHODS: We searched MEDLINE, EMBASE, Cochrane databases, and Scopus for studies of patients with VAAs. Studies were selected and appraised by pairs of independent reviewers. Meta-analysis was performed when appropriate. RESULTS: We included 80 observational studies that were mostly noncomparative. Data were available for 2845 aneurysms, comprising 1279 renal artery, 775 splenic artery, 359 hepatic artery, 226 pancreaticoduodenal and gastroduodenal arteries, 95 superior mesenteric artery, 87 celiac artery, 15 jejunal, ileal and colic arteries, and 9 gastric and gastroepiploic arteries. Differences in mortality between open and endovascular approaches were not statistically significant. The endovascular approach was used more often by surgeons. The endovascular approach was associated with shorter hospital stay and lower rates of cardiovascular complications but higher rates of reintervention. Postembolization syndrome rates ranged from 9% (renal) to 38% (splenic). Coil migration ranged from 8% (splenic) to 29% (renal). Otherwise, access site complication were low (<5%). Pseudoaneurysms tended to have higher mortality and reintervention rates. CONCLUSIONS: This systematic review provides event rates for outcomes important to patients with VAAs. Despite the low certainty warranted by the evidence, these rates along, with surgical expertise and anatomic feasibility, can help patients and surgeons in shared-decision making.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Barrionuevo P, Malas MB, Nejim B, et al. A systematic review and meta-analysis of the management of visceral artery aneurysms. J Vasc Surg. 2020. PMID: 32553135. doi:10.1016/j.jvs.2020.05.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。